• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Advanced Biomed Inc. (ADVB)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31
Fiscal Period		Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025
Total Assets		6,242,970$	6,512,343$	8,287,598$	4,504,152$		4,460,247$
Total Current Assets		5,844,133$	6,032,571$	7,731,148$	3,138,891$		3,051,110$
Cash and Cash Equivalents
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets		398,837$	479,772$	556,450$	1,365,261$		1,409,137$
Goodwill
Other Intangible Assets				20,325$	50,516$		118,998$
Physical Assets		281,270$	331,346$	355,274$	401,007$		524,528$
Other Noncurrent Assets		74,770$	83,027$
Assets Held for Sale in Long Term
Total Liabilities		3,238,846$	3,034,779$	4,157,815$	3,885,120$		2,796,989$
Total Current Liabilities		3,044,952$	2,889,128$	4,113,343$	3,828,794$		2,732,460$
Accounts Payable		641,587$	632,697$	618,520$	617,865$		620,476$
Short Term Debt
Short Term Capital Lease Obligations		27,934$	35,811$	138,357$	233,701$		62,211$
Other Current Liabilities
Total Noncurrent Liabilities		193,894$	145,651$	44,472$	56,326$		64,529$
Long Term Debt
Long Term Capital Lease Obligations		2,935$	5,879$	44,472$	56,326$		64,529$
Other Noncurrent Liabilities
Total Equity		3,004,124$	3,477,564$	4,129,783$	619,032$	1,093,830$	1,663,258$	(497,797$)	196,841$
Equity to Minority
Equity to Common Shareholders		3,004,124$	3,477,564$	4,129,783$	619,032$	1,093,830$	1,663,258$	(497,797$)	196,841$
Additional Paid-In Capital
Retained Earnings		(19,619,945$)	(19,233,044$)	(18,531,433$)	(17,147,559$)		(15,974,075$)
Treasury Stock
Capital Lease Obligations		30,869$	41,690$	182,829$	290,027$		126,740$

Copy Table ✓